
    
      The protocol was developed and initially implemented when the standard of care for Supportive
      Care (and oncology) follow-up at MSK was in-person visiting and home telemedicine was only in
      an early stage of use at the institution. During the COVID-19 crisis, all outpatient
      Supportive Care visits and most oncology visits at MSK have been handled via telemedicine to
      protect patient (and staff) safety.
    
  